Skip to main content
. 2021 Dec 23;181(4):1585–1596. doi: 10.1007/s00431-021-04347-x
What is Known:
A wide spectrum of rare syndromes manifesting in childhood is associated with an increased cancer risk.
For many of these syndromes, expert recommendations for management and tumor surveillance are available, although based on limited evidence.
What is New:
Evaluating current practice, our data attest significant shortcomings in tumor surveillance of children and adolescents with CPS even in a tertiary-care children’s hospital.
We clearly advocate a systematic and consistent integration of tumor surveillance into daily practice.